NFKB1 and cancer: Previous studies have implicated PARP7 in IFN-I signaling using PARP7 inhibitors in cancer cells, although the mechanism remained unclear with TBK1 and NF-κB suggested as potential targets (Yamada et al., 2016; Rasmussen et al., 2023).